# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and s...
Here's a roundup of top developments in the biotech space over the last 24 hours:
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled durin...
Citing the need to inspect a third-party contract packaging manufacturer, the U.S. Food and Drug Administration (FDA) has issue...
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run...
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an i...
Here's a roundup of top developments in the biotech space over the last 24 hours: